v3.26.1
Net Loss Per Share
6 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Net Loss Per Share

13. Net Loss Per Share

The following table presents the calculation of basic and diluted net loss per share applicable to common stockholders. Basic net loss per share is calculated by dividing net loss attributable to common shareholders by the weighted-average number of shares outstanding during the period which includes 42,538,910 of Pre-Funded Warrants and shares held in abeyance from date of issuance.

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(19,591,231

)

 

$

(9,915,523

)

 

$

(35,972,071

)

 

$

(23,594,258

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of shares outstanding – basic and diluted

 

 

174,571,543

 

 

 

90,009,625

 

 

 

173,445,493

 

 

 

89,774,703

 

Net loss per share applicable to common stockholders – basic and diluted

 

$

(0.11

)

 

$

(0.11

)

 

$

(0.21

)

 

$

(0.26

)

 

The Company’s potentially dilutive securities have been excluded from the computation of diluted net loss per share applicable to common stockholders, prior to the application of the treasury stock method, because their effect would have been antidilutive for the periods presented. Therefore, the weighted average number of shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The potentially dilutive securities that have been excluded from the computation of diluted net loss per share include stock options and warrants to purchase common stock, restricted common stock and for the six months ended June 30, 2025, shares of common stock issued as contingent consideration in connection with the acquisition of CorHepta, for which the vesting conditions had not been met. The Company excluded the following potential shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated:

 

 

 

Six months ended June 30,

 

 

 

2026

 

 

2025

 

Options to purchase shares of stock

 

 

51,407,711

 

 

 

37,020,275

 

Warrants to purchase shares of stock

 

 

119,381,067

 

 

 

121,972,253

 

Contingently issuable shares (see Note 10):

 

 

 

 

 

 

Restricted common stock

 

 

 

 

 

1,660,222

 

Contingent consideration

 

 

 

 

 

2,489,030

 

Total

 

 

170,788,778

 

 

 

163,141,780